ICH M10 has a nice section on Stability of the Analyte in Whole Blood
3.2.8
'4. Stability of the analyte in whole blood
Sufficient attention should be paid to the stability of the analyte in the sampled matrix (blood) directly
after collection from subjects and prior to preparation for storage to ensure that the concentrations
obtained by the analytical method reflect the concentrations of the analyte in the subject's blood at the
time of sample collection.
If the matrix used is plasma, the stability of the analyte in blood should be evaluated during method
development (e.g., using an exploratory method in blood) or during method validation. The results
should be provided in the Validation Report.'
This does reference possibly using an exploratory blood assay but many people in the industry have steered away more to a comparative approach as Joleen describes - spike, process some to the final sample matrix and store under validated conditions and then store the blood under appropriate conditions and then process and compare both using the validated assay. Not perfect in all situations but one that can work in many situations effectively without the development of a 'new' assay.
The key here is if the time is 5 mins or 24hrs it should be assessed and characterised the best you can and as Robert and Joleen have pointed out not always easy to do so good scientific judgement - for may labs just getting fresh blood can be a massive challenge.
Good luck let us know how you get on.
Tim
------------------------------
Timothy Sangster
Executive Director
Celerion
Lincoln NE
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------
Original Message:
Sent: 12-07-2022 11:29
From: Robert Kubiak
Subject: Blood processing for PK analysis
Hi Everybody,
Joleen makes a very good point – it's hard to accurately spike analyte into whole blood in SST. We are fortunate enough to have blood collection on site, and we had access to freshly collected (still warm!) blood in SST. The SST tubes were still under vacuum so spiking was done with a syringe; you puncture the septum and the vacuum in the tube "sucks in" the contents of the syringe. Our experiments were of "look/see" nature and much more work would be required to bring them up to validation standards. Our protein was a monoclonal antibody, so we didn't have to worry about binding to plasma proteins or penetrating cells. For proteins that do, designing a good experiment would take more thought. Good luck!
------------------------------
Robert Kubiak PhD
Senior Manager, R&D
AstraZeneca PLC
Gaithersburg MD
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
Original Message:
Sent: 12-07-2022 09:45
From: Joleen White
Subject: Blood processing for PK analysis
I agree with Robert and Tim that you will need to include this in your vaildation (can be an addendum). As Robert mentioned, you design an experiment where you are comparing prompt processing versus conditions that mimic the sample handling conditions. One caveat is that since you are spiking quickly in whole blood without the precision of volumetric pipetting, you are getting relative recovery rather than absolute recovery. Another is that when you are spiking samples into whole blood, if your molecule does partition into the cellular fraction, you will look like you are losing material when it is really equilibration (incurred samples would have already completed distribution in vivo). In this case, you may want to do some development experiments in plasma first since it can be processed immediately after collection as a baseline to evaluate distribution kinetics over a time course.
I am aware of an example where whole blood was transported by courier to a processing lab and stability was established to hold the whole blood for over 24 hours before processing the serum.
------------------------------
Joleen White Ph.D.
AAPS 2022 Global Health Community Chair
AAPS 2022 Bioanalytical Community Past Chair
Head of Bioassay Development and Operations
Gates Medical Research Institute
Cambridge MA
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
Original Message:
Sent: 12-01-2022 14:11
From: Anonymous Member
Subject: Blood processing for PK analysis
This message was posted by a user wishing to remain anonymous
Hi Friends
I have question about the impacted of delayed processing in assessing PK for proteins.
We have a biologic (protein) that has collection timepoints at 16 and 20 hrs. on D7 for terminal half-life determination. We will be able to draw the whole blood however there would be no staff to process this immediately into serum at the time of collection. The blood is collected in SST tubes and allow to clot for 30 minutes, centrifuged and aliquots are made before freezing. However, at these timepoints the SST tube will be draw but not processed immediately. Any prior experience with other large molecule studies on what to do at these later timepoints when blood cannot be processed immediately? How is the blood handled?
Thank you!